| NCT05371964 | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis | RECRUITING | PHASE1 | 2022-05-04 | 2028-08 | 2027-02 |
| NCT04576156 | A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment | RECRUITING | PHASE3 | 2021-04-12 | 2028-06-30 | 2028-06-30 |
| NCT02426086 | Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor | COMPLETED | PHASE2 | 2015-08-28 | 2020-02-07 | 2018-04-26 |
| NCT01731951 | Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis | COMPLETED | PHASE2 | 2012-10-29 | 2018-05-24 | 2018-05-24 |
| NCT01243073 | Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera | COMPLETED | PHASE2 | 2010-12 | 2015-04 | 2013-10 |
| NCT01242930 | Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma | COMPLETED | PHASE2 | 2010-11 | 2014-11 | 2014-11 |
| NCT01256762 | Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer | COMPLETED | PHASE2 | 2010-11 | 2012-12 | 2012-10 |
| NCT01137968 | Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) | COMPLETED | PHASE2 | 2010-05 | 2013-09 | 2013-09 |
| NCT00732056 | A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer | COMPLETED | PHASE1 | 2008-07 | 2012-03 | 2011-09 |
| NCT00718601 | Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma | COMPLETED | PHASE1 | 2008-07 | 2011-10 | 2011-10 |
| NCT00594126 | Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma | COMPLETED | PHASE1 | 2007-11 | 2011-07 | 2011-07 |
| NCT00510445 | Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer | COMPLETED | PHASE1 | 2007-07 | 2011-04 | 2011-04 |
| NCT00310895 | Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies | COMPLETED | PHASE1 | 2006-03 | 2013-03 | 2013-03 |
| NCT00124189 | Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD) | COMPLETED | PHASE1 | 2005-07 | 2013-03 | 2013-03 |